BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,182,466 | -17.2% | 57,829 | 0.0% | 0.24% | -16.7% |
| Q2 2023 | $2,634,689 | +12.3% | 57,829 | 0.0% | 0.29% | +8.1% |
| Q1 2023 | $2,345,544 | -20.4% | 57,829 | 0.0% | 0.27% | -20.8% |
| Q4 2022 | $2,947,544 | -5.4% | 57,829 | 0.0% | 0.34% | -15.8% |
| Q3 2022 | $3,115,000 | -16.1% | 57,829 | 0.0% | 0.41% | -12.3% |
| Q2 2022 | $3,714,000 | -17.2% | 57,829 | 0.0% | 0.46% | -2.3% |
| Q1 2022 | $4,484,000 | -9.7% | 57,829 | 0.0% | 0.47% | -11.4% |
| Q4 2021 | $4,964,000 | +6.7% | 57,829 | 0.0% | 0.54% | -7.3% |
| Q3 2021 | $4,651,000 | -0.1% | 57,829 | 0.0% | 0.58% | -5.3% |
| Q2 2021 | $4,655,000 | -4.6% | 57,829 | 0.0% | 0.61% | -9.5% |
| Q1 2021 | $4,877,000 | +5.1% | 57,829 | 0.0% | 0.67% | -10.9% |
| Q4 2020 | $4,640,000 | -0.2% | 57,829 | 0.0% | 0.76% | -21.2% |
| Q3 2020 | $4,651,000 | -6.6% | 57,829 | 0.0% | 0.96% | -14.8% |
| Q2 2020 | $4,979,000 | -14.2% | 57,829 | -19.1% | 1.12% | -9.4% |
| Q1 2020 | $5,806,000 | -2.9% | 71,515 | 0.0% | 1.24% | +38.3% |
| Q4 2019 | $5,980,000 | -4.4% | 71,515 | 0.0% | 0.90% | -10.4% |
| Q3 2019 | $6,255,000 | +6.8% | 71,515 | 0.0% | 1.00% | +7.2% |
| Q2 2019 | $5,857,000 | +2.8% | 71,515 | 0.0% | 0.94% | +1.1% |
| Q1 2019 | $5,699,000 | +21.1% | 71,515 | 0.0% | 0.92% | +9.0% |
| Q4 2018 | $4,707,000 | -14.1% | 71,515 | 0.0% | 0.85% | -5.8% |
| Q3 2018 | $5,478,000 | +3.8% | 71,515 | 0.0% | 0.90% | -2.3% |
| Q2 2018 | $5,278,000 | +13.5% | 71,515 | 0.0% | 0.92% | +4.4% |
| Q1 2018 | $4,651,000 | +0.6% | 71,515 | 0.0% | 0.88% | -0.3% |
| Q4 2017 | $4,623,000 | +3.0% | 71,515 | 0.0% | 0.89% | -1.1% |
| Q3 2017 | $4,488,000 | +3.6% | 71,515 | 0.0% | 0.90% | +0.1% |
| Q2 2017 | $4,330,000 | +16.7% | 71,515 | 0.0% | 0.90% | +18.4% |
| Q1 2017 | $3,709,000 | +17.0% | 71,515 | 0.0% | 0.76% | +12.7% |
| Q4 2016 | $3,171,000 | -6.8% | 71,515 | 0.0% | 0.67% | -14.2% |
| Q3 2016 | $3,404,000 | +5.3% | 71,515 | 0.0% | 0.78% | -0.5% |
| Q2 2016 | $3,234,000 | +6.1% | 71,515 | -3.6% | 0.79% | -5.1% |
| Q1 2016 | $3,048,000 | +7.7% | 74,200 | 0.0% | 0.83% | +5.7% |
| Q4 2015 | $2,831,000 | +16.2% | 74,200 | 0.0% | 0.78% | +6.2% |
| Q3 2015 | $2,437,000 | -41.9% | 74,200 | +23.7% | 0.74% | -41.3% |
| Q2 2015 | $4,196,000 | +2.1% | 60,000 | 0.0% | 1.26% | -4.4% |
| Q1 2015 | $4,110,000 | +14.5% | 60,000 | +22.4% | 1.31% | +16.2% |
| Q4 2014 | $3,591,000 | +16.4% | 49,000 | +14.0% | 1.13% | +3.3% |
| Q3 2014 | $3,086,000 | -25.4% | 43,000 | -24.9% | 1.09% | -6.0% |
| Q2 2014 | $4,139,000 | -1.7% | 57,250 | 0.0% | 1.16% | -11.9% |
| Q1 2014 | $4,212,000 | +11.3% | 57,250 | +5.2% | 1.32% | -7.0% |
| Q4 2013 | $3,785,000 | +5.9% | 54,420 | 0.0% | 1.42% | +12.9% |
| Q3 2013 | $3,575,000 | +12.2% | 54,420 | +18.3% | 1.26% | +6.9% |
| Q2 2013 | $3,186,000 | – | 46,000 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |